apricus biosciences inc
(APRI:Consolidated Issue listed on NASDAQ Capital Market)
Ghassan K. Abou-Alfa M.D.
Former Member of the Clinical Advisory Board, Apricus Biosciences, Inc.
|Age||Total Calculated Compensation||This person is connected to 36 board members in 1 different organizations across 2 different industries.|
See Board Relationships
Dr. Ghassan K. Abou-Alfa served as a Member of the Advisory Board at Apricus Biosciences, Inc. since October 2010. Dr. Abou-Alfa is a board-certified medical oncologist at Memorial Sloan-Kettering Cancer Center, specializing in primary liver cancer (hepatocellular carcinoma), pancreas, gallbladder, and bile duct tumors. He is involved in research focusing on improving the effectiveness of cancer therapy by incorporating small, novel biological molecules that target cancer ...
11975 El Camino RealPhone: 858-222-8041
San Diego, California 92130
Board Members Memberships*There is no Board Members Memberships data available.
American University of Beirut
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Ian C. Read||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|Andrew Philip Witty||Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee|
|John C. Lechleiter Ph.D.||Chairman, Chief Executive Officer and President|
Eli Lilly and Company
|$1.5M||Compensation as of Fiscal Year 2013.|